HR-Positive and Triple-Negative Metastatic Breast Cancer — An Interview with Dr Laura Huppert on Optimal Integration of ADCs into Treatment
Breast Cancer Update
00:00
How do you sequence T‑DXd versus trop‑2 ADCs in HR+ and TNBC?
Dr Huppert explains favoring T‑DXd early in HR+ and prioritizing SG first in TNBC, with individualized exceptions.
Play episode from 29:03
Transcript
